首页> 外国专利> A eukaryotic intein (Cne PRP8) from Cryptococcus neoformans and potential use as a molecular target for treatment of severe microbial infection

A eukaryotic intein (Cne PRP8) from Cryptococcus neoformans and potential use as a molecular target for treatment of severe microbial infection

机译:新型隐球菌的真核内含子(Cne PRP8)及其作为治疗严重微生物感染的分子靶标的潜在用途

摘要

Inteins are not known from any mammalian gene and as such they are potential molecular targets with regard to the treatment of severe microbial infections. Cryptococcus neoformans is one of the principal yeast pathogens in humans. It can cause incurable, frequently fatal infections and has become especially significant as a predominant secondary pathogen associated with pandemic HIV infection. The most common clinical manifestation is chronic meningitis, which may be accompanied by lesions on the skin and lungs. An isolated intein, Cne PRP, obtained from C.neoformans strain Cn3511 is described in addition to a method for screening an agent for antimicrobial activity against a microorganism comprising detecting inhibitors of the intein by monitoring intein function.
机译:从任何哺乳动物基因中都不知道内含肽,因此它们是治疗严重微生物感染的潜在分子靶标。新型隐球菌是人类主要的酵母菌病原体之一。它可以引起不可治愈的,经常致命的感染,作为与大流行HIV感染相关的主要继发性病原体尤其重要。最常见的临床表现是慢性脑膜炎,可能伴有皮肤和肺部病变。除了用于筛选针对微生物的抗微生物活性的试剂的方法之外,还描述了从新奇异球菌菌株Cn3511获得的分离的内含肽Cne PRP,该方法包括通过监测内含肽功能来检测内含肽的抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号